summary
Introduced
05/13/2019
05/13/2019
In Committee
05/13/2019
05/13/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
191st General Court
Bill Summary
Relative to informed consent for opioid treatment for pain. Public Health.
AI Summary
This bill requires healthcare practitioners to discuss certain risks with patients before issuing an initial prescription for a Schedule II controlled substance or other opioid drug for acute or chronic pain, as well as before issuing the third prescription in a course of treatment. The risks that must be discussed include addiction, overdose, and the dangers of mixing opioids with alcohol, benzodiazepines, and other central nervous system depressants. Practitioners must also discuss the necessity of the prescription, alternative treatments, and the risks of physical or psychological dependence on the opioid drug. The practitioner must document in the patient's medical record that this discussion has taken place.
Committee Categories
Health and Social Services
Sponsors (6)
Brian Ashe (D),
Carole Fiola (D),
Mike Moore (D),
Tram Nguyen (D),
Paul Schmid (D),
Alan Silvia (D),
Last Action
Accompanied a study order, see H4449 (on 02/24/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/191/H3779 |
| Bill | https://malegislature.gov/Bills/191/H3779.pdf |
Loading...